Improving the quality of life and improving prognosis in cardiology: two sides of the same coin. Overview of the satellite symposium
https://doi.org/10.51793/OS.2023.26.12.013
Abstract
Background. Within the framework of the Russian National Congress of Cardiology, on its opening day on September 21, 2023, a satellite symposium «Improving the quality of life and improving the prognosis in cardiology: two sides of the same coin» was held under the chairmanship of Doctors of Medical Sciences, Professors Yu. A. Karpov and O. D. Ostroumova.
Objective. To present an overview of the reports made at the symposium by O. D. Ostroumova «"Old" and "new" risk factors for cardiovascular complications in patients with arterial hypertension» and A. O. Nedoshivin «Quality of life of a patient with stable ischemic disease: a surrogate endpoint or the most important goal of treatment?» in order to raise awareness of cardiologists, therapists, general practitioners and geriatricians about modern approaches to drug therapy of patients with arterial hypertension and coronary heart disease, taking into account age, comorbidity, balance of efficacy and safety of drugs, especially in the treatment of elderly patients.
About the Author
I. A. Belokrylov
State Budgetary Healthcare Institution Scientific and Practical Center of Specialized Medical Care for Children named after V. F. Voino-Yasenetsky
Россия
Россия
Ivan Belokrylov, Researcher
38 Aviatorov str., Moscow, 119620
References
1. https://scardio.ru/events/rossiyskiy_nacionalnyy_kongress_kardiologov/rossiyskiy_nacionalnyy_kongress_kardiologov_2023/.
2. https://event.scardio.ru/event/online/free/492.
3. https://medsoftpro.ru/kalkulyatory/score2-scale.html.
4. 2023 ESH Guidelines for the management of arterial hypertension: https://pubmed.ncbi.nlm.nih.gov/37345492/.
5. Clinical recommendations «Comorbid pathology in clinical practice». Cardiovascular therapy and prevention. 2019; 18 (1): 5-66. (In Russ.)
6. Clinical recommendations «Arterial hypertension in adults», 2019 (In Russ.) https://scardio.ru/content/Guidelines/project/Project_Rek_AG_2019.pdf.
7. Van Liefde I., Vauquelin G. Sartan-AT1 receptor interactions: in vitro evidence for insurmountable antagonism and inverse agonism. Molecular and Cellular Endocrinology, 2009, 302 (2): 237-57.
8. Nixon R. M., Muller E., Lowy A., Falvey H. Valsartan vs. оther angiotensin II receptor blockers in the treatment of hypertension: a meta-analytical approach. Int. J. Clin. Pract. 2009, 63 (5): 766-775.
9. Ангиаканд: инструкция к применению. [Angiacand: instructions for use. (In Russ.)] https://medi.ru/instrukciya/angiakand_410/.
10. Granger C. B., McMurray J. J., Yusuf S., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin converting enzyme inhibitors: the CHARM-Alternative trial. Lancet. 2003; 362: 772-776.
11. Saxby B. K., Harrington F., Wesnes K. A., McKeith I. G., Ford G. A. Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. Neurology. 2008; 70 (19 Pt. 2): 1858-1866.
12. Fosinap: instructions for use. (In Russ.)] https://medi.ru/instrukciya/fozinap_132/
13. Marin R., Ruilope L. M., Aljama P., et al. A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease. J. Hypertension. 2001; 19: 1871-1876.
14. Karpov Yu. A., Mareev V. Yu., Chazova I. E. Russian programs assessing efficacy of fosinopril treatment in patients with arterial hypertension and heart failure. Three F Project (FLAG, FASON, FAGOT). Serdechnaya nedostatochnost. 2003; 5 (4): 2-6. (In Russ).
15. Brown E. J., Chew P. H., MacLean A., et al. Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group. Am. J. Cardiol. 2015; 75 (8): 596-600.
16. 10 leading causes of death in the world. Vsemirnaya organizatsiya zdravookhraneniya. 2020. URL: https://www.who.int/ru/news-room/factsheets/detail/the-top-10-causes-of-death (Accessed: 14.05.23). (In Russ.)
17. Larina V. N. and Samorodskaya I. V. Chronic Coronary Syndromes: Guidelines for the Diagnosis and Management (European Society of Cardiology, 2019). Lechebnoe delo. 2019; 4: 1-10. (In Russ.)
18. EUROASPIRE V European survey of cardiovascular disease prevention and diabetes. https://www.escardio.org/Research/Registries-&-surveys/Observational-research-programme/euroaspire-v.
19. Deprenorm®OD: instructions for use. (In Russ.) https://medi.ru/instrukciya/deprenorm-od_19358/.
20. Deprenorm®МВ: instructions for use. (In Russ.) https://medi.ru/instrukciya/deprenorm-mb_9369/.
21. Frishman W. H. Cardiology in review. 2007; 15: 257-263.
Review
For citations:
Belokrylov I.A. Improving the quality of life and improving prognosis in cardiology: two sides of the same coin. Overview of the satellite symposium. Lechaschi Vrach. 2023;(12):90-95. (In Russ.) https://doi.org/10.51793/OS.2023.26.12.013
Views:
148
JATS XML
Email this article 
